Related Experiment Video
Updated: Aug 13, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin
I Kalajzic1, Z Kalajzic, M M Hurley
1Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Abstract:
Fibroblast growth factor 2 (FGF2) and noggin are two unrelated ligands of two distinctly different signaling pathways that have a similar inhibitory effect on osteoblast differentiation. Because of their differences, we postulated that they probably acted at a different stage within the osteoprogenitor differentiation pathway. This study was performed on primary murine bone cell cultures under conditions where alkaline phosphatase (AP) and type I collagen expression (Col1a1) were observed by day 7 (preosteoblast stage), followed by bone syaloprotein (BSP) at day 11 (early osteoblast) and osteocalcin (OC) by day 15-18 (mature osteoblast stage). FGF2 completely inhibited expression of AP and the mRNA transcript for Col1a1, while noggin showed only a partial inhibition of these markers of preosteoblast differentiation. However, the markers of differentiated osteoblasts (BSP and OC) were completely inhibited in both the FGF2 and noggin treated cultures, suggesting that noggin acts at later point in the osteoprogenitor differentiation pathway than FGF2. To further verify that the inhibition was occurring at a different stage of osteoblasts development, primary cultures derived from transgenic mice harboring segments of the collagen promoter driving green fluorescent protein (GFP) that activate at different levels of osteoblast differentiation were analyzed. Consistent with the endogenous markers, pOBCol3.6GFP and pOBCOL2.3GFP transgene activity was completely inhibited by continuous addition of FGF2, while noggin showed partial inhibition of pOBCol3.6GFP and complete inhibition of the pOBCol2.3GFP transgene. Upon removal of either agent, endogenous and GFP markers of osteoblast differentiation reappeared although at a different temporal pattern. This work demonstrates that FGF2 and noggin can reversibly modulate osteoblast lineage differentiation at different maturational stages. These agents may be useful to enrich for and maintain a population of osteoprogenitor cells at a defined stage of differentiation.
Insights
Fibroblast growth factor 2 (FGF2) and noggin reversibly inhibit osteoblast differentiation at distinct stages. FGF2 impacts early stages, while noggin affects later stages, offering potential for cell population control.
Area of Science:
- Cell Biology
- Developmental Biology
- Biochemistry
Background:
- Osteoblast differentiation is a complex process involving sequential gene expression.
- Fibroblast growth factor 2 (FGF2) and noggin are signaling molecules with known roles in development.
- Both FGF2 and noggin have been observed to inhibit osteoblast differentiation.
Purpose of the Study:
- To investigate the distinct roles of FGF2 and noggin in osteoblast differentiation.
- To determine the specific stages of osteoprogenitor development modulated by FGF2 and noggin.
- To explore the potential of FGF2 and noggin for controlling osteoblast cell populations.
Main Methods:
- Primary murine bone cell cultures were used to assess osteoblast differentiation markers.
- Gene expression of alkaline phosphatase (AP), type I collagen (Col1a1), bone sialoprotein (BSP), and osteocalcin (OC) were analyzed.
- Transgenic mice with collagen promoter-driven GFP reporters were utilized to track differentiation stages.
Main Results:
- FGF2 completely inhibited early differentiation markers (AP, Col1a1), while noggin showed partial inhibition.
- Both FGF2 and noggin completely inhibited later differentiation markers (BSP, OC).
- Transgene activity confirmed FGF2's effect on early stages and noggin's on later stages, with reversible modulation observed upon agent removal.
Conclusions:
- FGF2 and noggin modulate osteoblast lineage differentiation at different maturational stages.
- The differential effects suggest distinct mechanisms of action for FGF2 and noggin.
- These findings indicate FGF2 and noggin can be used to enrich and maintain specific osteoprogenitor cell populations.
More Related Videos
10:32Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
05:25Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement
Published on: July 21, 2023
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Bone Formation by Endochondral Ossification